Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1998;32:473-481

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yang, H.
Right arrow Articles by Raizada, M. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yang, H.
Right arrow Articles by Raizada, M. K.

(Hypertension. 1998;32:473-481.)
© 1998 American Heart Association, Inc.


Scientific Contributions

MAP Kinase–Independent Signaling in Angiotensin II Regulation of Neuromodulation in SHR Neurons

Hong Yang; ; Mohan K. Raizada

From the Department of Physiology, University of Florida, College of Medicine, Gainesville, Fla.

Correspondence to Dr Mohan K. Raizada, Department of Physiology, University of Florida, PO Box 100274, JHMHC, 1600 SW Archer Rd, Gainesville, FL 32610. E-mail mraizada{at}phys.med.ufl.edu

Abstract—Angiotensin II (Ang II), via its interaction with the angiotensin type 1 (AT1) receptor subtype, causes enhanced stimulation of norepinephrine (NE) neuromodulation. This involves increased transcription of NE transporter, tyrosine hydroxylase, and dopamine ß-hydroxylase genes in Wistar-Kyoto rat (WKY) brain neurons. AT1 receptor–mediated regulation of certain signaling events (such as activation of the Ras-Raf-1–mitogen activated protein (MAP) kinase signaling pathway, nuclear translocation of transcription factors such as Fos and Jun, and the interactions of these factors with AP-1 binding sites) is involved in this NE neuromodulation (Lu et al. J Cell Biol. 1996;135:1609–1617). The aim of this study was to compare the signal transduction mechanism of Ang II regulation of NE neuromodulation in WKY and spontaneously hypertensive rat (SHR) brain neurons, in view of the fact that AT1 receptor expression and Ang II stimulation of NE neuromodulation are higher in SHR neurons compared with WKY neurons. Despite this hyperactivity, Ang II stimulation of Ras, Raf-1, and MAP kinase activities was comparable between the neurons from WKY and SHR. Similarly, central injections of Ang II caused a comparable stimulation of MAP kinase in the hypothalamic and brain stem areas of adult WKY and SHR. Inhibition of MAP kinase by either an MAP kinase kinase inhibitor (PD98059) or an MAP kinase antisense oligonucleotide completely attenuated the stimulatory effects of Ang II on [3H]-NE uptake, NE transporter mRNA, and tyrosine hydroxylase mRNA levels in WKY neurons. These treatments resulted in only 43% to 50% inhibition of [3H]-NE uptake and NE transporter and tyrosine hydroxylase mRNAs in SHR neurons. Thus, Ang II stimulation of NE neuromodulation was completely blocked by MAP kinase inhibition in WKY neurons and only partially blocked in the SHR neurons. These observations suggest the presence of an additional signal transduction pathway involved in NE neuromodulation in SHR neurons that is independent of the MAP kinase pathway.


Key Words: angiotensin • intracellular signaling • MAP kinase • neurons • norepinephrine • rats, inbred SHR




This article has been cited by other articles:


Home page
StrokeHome page
C. Lecrux, O. Nicole, L. Chazalviel, C. Catone, J. Chuquet, E. T. MacKenzie, and O. Touzani
Spontaneously Hypertensive Rats Are Highly Vulnerable to AMPA-Induced Brain Lesions
Stroke, November 1, 2007; 38(11): 3007 - 3015.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
D. N. Mayorov
Brain superoxide as a key regulator of the cardiovascular response to emotional stress in rabbits
Exp Physiol, May 1, 2007; 92(3): 471 - 479.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. Dipace, U. Sung, F. Binda, R. D. Blakely, and A. Galli
Amphetamine Induces a Calcium/Calmodulin-Dependent Protein Kinase II-Dependent Reduction in Norepinephrine Transporter Surface Expression Linked to Changes in Syntaxin 1A/Transporter Complexes
Mol. Pharmacol., January 1, 2007; 71(1): 230 - 239.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
H. Yang, G. Shaw, and M. K. Raizada
ANG II stimulation of neuritogenesis involves protein kinase B in brain neurons
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2002; 283(1): R107 - R114.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. Seyedabadi, A. K. Goodchild, and P. M. Pilowsky
Differential Role of Kinases in Brain Stem of Hypertensive and Normotensive Rats
Hypertension, November 1, 2001; 38(5): 1087 - 1092.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
H. Yang, X. Wang, and M. K. Raizada
Characterization of Signal Transduction Pathway in Neurotropic Action of Angiotensin II in Brain Neurons
Endocrinology, August 1, 2001; 142(8): 3502 - 3511.
[Abstract] [Full Text] [PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
J. Culman, J. Baulmann, A. Blume, and T. Unger
Review: The renin-angiotensin system in the brain: an update
Journal of Renin-Angiotensin-Aldosterone System, June 1, 2001; 2(2): 96 - 102.
[PDF]


Home page
J. Neurosci.Home page
H. Yang and M. K. Raizada
Role of Phosphatidylinositol 3-Kinase in Angiotensin II Regulation of Norepinephrine Neuromodulation in Brain Neurons of the Spontaneously Hypertensive Rat
J. Neurosci., April 1, 1999; 19(7): 2413 - 2423.
[Abstract] [Full Text] [PDF]